» Articles » PMID: 2543747

Use of Human Adenovirus-based Vectors for Antigen Expression in Animals

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1989 Feb 1
PMID 2543747
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

An infectious recombinant human adenovirus type 5 (Ad5) vector, AdG12, which carries the glycoprotein gene of vesicular stomatitis virus (VSV) and expresses that gene in cultured HeLa cells was used to examine the host range of insert expression by human Ad vectors. The VSV glycoprotein was expressed in bovine, canine and murine cells when infected with AdG12 in culture. These cell lines are respectively permissive, non-permissive and semi-permissive for human Ad5 replication. Administration of the AdG12 vector to calves, piglets or dogs by either the subcutaneous or oral route resulted in the production of high titres of neutralizing antibodies to VSV. Mice injected intraperitoneally with the vector produced neutralizing antibodies and were protected against subsequent intravenous challenge with normally lethal doses of VSV. This work demonstrates the utility of human adenoviral vectors for antigen expression in a number of non-human cell lines and for the induction of an immune response to the delivered antigen in a number of species.

Citing Articles

A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs.

Zhang Y, Fang L, Wang Z, Zhang C, Zhao J, Daemi H Emerg Microbes Infect. 2024; 13(1):2300461.

PMID: 38164714 PMC: 10810672. DOI: 10.1080/22221751.2023.2300461.


Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses.

Krutzke L, Allmendinger E, Hirt K, Kochanek S Hum Gene Ther. 2020; 31(19-20):1100-1113.

PMID: 32552215 PMC: 7585625. DOI: 10.1089/hum.2020.045.


Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes.

Kratzer R, Espenlaub S, Hoffmeister A, Kron M, Kreppel F PLoS One. 2017; 12(5):e0176852.

PMID: 28472163 PMC: 5417563. DOI: 10.1371/journal.pone.0176852.


Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Wang S, Liu H, Zhang X, Qian F Protein Cell. 2015; 6(7):480-503.

PMID: 25944045 PMC: 4491048. DOI: 10.1007/s13238-015-0164-2.


Liver-targeted gene therapy: Approaches and challenges.

Aravalli R, Belcher J, Steer C Liver Transpl. 2015; 21(6):718-37.

PMID: 25824605 PMC: 9353592. DOI: 10.1002/lt.24122.